CK Biotech Laboratory

CK Biotech Laboratory Limited is the primary research and development arm of CK Life Sciences Int'l., (Holdings) Inc., a member of the CK Hutchison Group. Based in Hong Kong, the company focuses on the discovery and development of biotechnology products in the fields of human health, nutraceuticals, and environmental sustainability. Its clinical pipeline features a therapeutic cancer vaccine for melanoma (seviprotimut-L) and a tetrodotoxin-based analgesic for the treatment of cancer-related pain. Additionally, the company develops eco-friendly agricultural products, including fertilizers and bioremediation solutions, leveraging its proprietary immune enhancement and environmental technology platforms. Through its parent company, it maintains a global presence with operations and clinical trials spanning North America, Australia, and Asia.